What is Atara Biotherapeutics, Inc's Market Cap?

Atara Biotherapeutics, Inc's Market Cap is $102.7M, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's Enterprise Value?

Atara Biotherapeutics, Inc's Enterprise Value is $92.8M, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's Price / Sales?

Atara Biotherapeutics, Inc's Price / Sales is 16.6×, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's EV / Revenue?

Atara Biotherapeutics, Inc's EV / Revenue is 15.0×, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's EV / EBITDA?

Atara Biotherapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's Revenue (TTM)?

Atara Biotherapeutics, Inc's Revenue (TTM) is $6.2M, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's Net Income (TTM)?

Atara Biotherapeutics, Inc's Net Income (TTM) is -$16.7M, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's EBITDA?

Atara Biotherapeutics, Inc's EBITDA is -$14.1M, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's Diluted EPS (TTM)?

Atara Biotherapeutics, Inc's Diluted EPS (TTM) is -1.66, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's EBITDA Margin?

Atara Biotherapeutics, Inc's EBITDA Margin is -227.6%, based on as-reported figures from SEC (XBRL) filings.

Atara Biotherapeutics, Inc (ATRA) Financial Statements

Atara Biotherapeutics, Inc

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG005Q3MR36

XNAS · usd

10.23▲ 0.47 (4.82%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close9.76

Day's Range10.23 – 11.33

52-Week Range3.92 – 19.15

Volume106.6K

Avg Volume52.0K

Share Statistics

Shares Outstanding

Employees14

ExchangeXNAS

Listed2014-10-16

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Atara Biotherapeutics, Inc (ATRA)

What is Atara Biotherapeutics, Inc's Market Cap?: Atara Biotherapeutics, Inc's Market Cap is $102.7M, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's Enterprise Value?: Atara Biotherapeutics, Inc's Enterprise Value is $92.8M, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's Price / Sales?: Atara Biotherapeutics, Inc's Price / Sales is 16.6×, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's EV / Revenue?: Atara Biotherapeutics, Inc's EV / Revenue is 15.0×, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's EV / EBITDA?: Atara Biotherapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's Revenue (TTM)?: Atara Biotherapeutics, Inc's Revenue (TTM) is $6.2M, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's Net Income (TTM)?: Atara Biotherapeutics, Inc's Net Income (TTM) is -$16.7M, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's EBITDA?: Atara Biotherapeutics, Inc's EBITDA is -$14.1M, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's Diluted EPS (TTM)?: Atara Biotherapeutics, Inc's Diluted EPS (TTM) is -1.66, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's EBITDA Margin?: Atara Biotherapeutics, Inc's EBITDA Margin is -227.6%, based on as-reported figures from SEC (XBRL) filings.